Provider-initiated HIV counseling and testing of out patients at community hospitals in Thailand: an economic evaluation using the Markov model

1. UNAIDS. 2008 Report on the global AIDS epidemic. Geneva: WHO Library Cataloguing-in-Publication Data, 2008.Search in Google Scholar

2. Pongpun S, Poolkasorn S, Kaesaudomthub V, Pliput T. Situation of HIV infection in Thailand 2007. Nonthaburi: Bureau of Epidemiology, Department of Disease Control, Ministry of Public Health; 2008.Search in Google Scholar

3. Bureau of Epidemiology, Department of Disease Control, Ministry of Public Health of Thailand. HIV prevention and implementation in men who have sex with men. Nonthaburi: Printing House of the War Veterans Organization of Thailand; 2008.Search in Google Scholar

4. Chasombat S, McConnell MS, Siangphoe U, Yuktanont P, Jirawattanapisal T, Fox K, et al. National expansion of antiretroviral treatment in Thailand, 2000-2007: program scale-up and patient outcomes. J Acquir Immune Defic Syndr. 2009; 50:506-12.10.1097/QAI.0b013e3181967602Search in Google Scholar

5. The Thai Working Group on HIV/AIDS Projections. The Asian epidemic model (AEM) projections for HIV/AIDS in Thailand: 2005-2025. Family Health International (FHI) and Bureau of AIDS, TB and STIs, Department of Disease Control, Ministry of Public Health, Thailand. 2008.Search in Google Scholar

6. Revenga A, Over M, Masaki E, Peerapatanapokin W, Gold J, Tangcharoensathien V, et al. The economics of effective AIDS treatment: evaluating policy options for Thailand. Washington DC: The World Bank, 2006.10.1596/978-0-8213-6755-1Search in Google Scholar

7. Manosuthi W, Chaovavanich A, Tansuphaswadikul S, Prasithsirikul W, Inthong Y, Chottanapund S, et al. Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resourcelimited setting. J Infect. 2007; 55:464-9.10.1016/j.jinf.2007.07.002Search in Google Scholar

8. Ormaasen V, Sandvik L, Dudman SG, Bruun JN. HIV related and non-HIV related mortality before and after the introduction of highly active antiretroviral therapy (HAART) in Norway compared to the general population. Scand J Infect Dis. 2007; 39:51-7.10.1080/00365540600904779Search in Google Scholar

9. Garcia F, de Lazzari E, Plana M, Castro P, Mestre G, Nomdedeu M, et al. Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count. J Acquir Immune Defic Syndr. 2004; 36:702-13.10.1097/00126334-200406010-00007Search in Google Scholar

10. Egger M, May M, Chene G, Phillips AN, Ledergerber B, Dabis F, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002; 360:119-29.10.1016/S0140-6736(02)09411-4Search in Google Scholar

11. Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009; 360:1815-26.10.1056/NEJMoa0807252285455519339714Search in Google Scholar

12. Lapadula G, Torti C, Maggiolo F, Casari S, Suter F, Minoli L, et al. Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3. Antivir Ther. 2007; 12:941-7.10.1177/135965350701200611Search in Google Scholar

13. Center for Disease Control and Prevention. Recommendations for HIV testing services for inpatients and outpatients in acute-care hospital settings. MMWR (Mortality Morbidity Weekly Report) Recomm Rep. 1993; 42:1-6.Search in Google Scholar

14. Center for Disease Control and Prevention. Revised recommendations for HIV screening of pregnant women. MMWR (Mortality Morbidity Weekly Report). Recomm Rep. 2001; 50:63-85.Search in Google Scholar

15. Walensky RP, Weinstein MC, Kimmel AD, Seage Iii GR, Losina E, Sax PE, et al. Routine human immunodeficiency virus testing: an economic evaluation of current guidelines. Am J Med. 2005; 118: 292-300.10.1016/j.amjmed.2004.07.05515745728Open DOISearch in Google Scholar

16. Paltiel AD, Walensky RP, Schackman BR, Seage GR 3rd, Mercincavage LM, Weinstein MC, et al. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs. Ann Intern Med. 2006; 145:797-806.10.7326/0003-4819-145-11-200612050-0000417146064Search in Google Scholar

17. Paltiel AD, Weinstein MC, Kimmel AD, Seage GR, 3rd, Losina E, Zhang H, et al. Expanded screening for HIV in the United States-an analysis of costeffectiveness. N Engl J Med. 2005; 352:586-95.10.1056/NEJMsa04208815703423Search in Google Scholar

18. Sanders GD, Bayoumi AM, Sundaram V, Bilir SP, Neukermans CP, Rydzak CE, et al. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med. 2005; 352:570-85.10.1056/NEJMsa04265715703422Search in Google Scholar

19. Resch S, Altice FL, Paltiel AD. Cost-effectiveness of HIV screening for incarcerated pregnant women. J Acquir Immune Defic Syndr. 2005; 38:163-73.10.1097/01.qai.0000146598.40301.e615671801Search in Google Scholar

20. Center for Disease Control and Prevention. Revised recommendations for HIV testing of adult, adolescents, and pregnant woman in health-care setting. MMWR (Mortality Morbidity Weekly Report) Recomm Rep. 2006; 55:1-17.Search in Google Scholar

21. WHO/UNAIDS. Guidance on provider-initiated HIV testing and counselling in health facilities. Geneva:WHO press, 2007.Search in Google Scholar

22. Teerawattananon Y, Leelukkanaveera Y, Hanvoravongchai P, Thavorncharoensap M, Ingsrisawang L, Tantivess S, et al. Provider-initiated HIV/AIDS counseling and testing at healthcare facilities in Thailand: cluster-randomisation trial. J Develop Effect. 2009; 1:450-69.10.1080/19439340903373976Search in Google Scholar

23. Fox-Rushby J, Cairns J. Economic Evaluation. Berkshire:Open University Press; 2008.Search in Google Scholar

24. Fylkesnes K, Siziya S. A randomized trial on acceptability of voluntary HIV counseling and testing. Trop Med Int Health. 2004; 9:566-72.10.1111/j.1365-3156.2004.01231.x15117300Open DOISearch in Google Scholar

25. Nuwaha F, Kabatesi D, Muganwa M, Whalen CC. Factors influencing acceptability of voluntary counselling and testing for HIV in Bushenyi district of Uganda. East Afr Med J. 2002; 79:626-32.10.4314/eamj.v79i12.8669287131512678445Search in Google Scholar

26. Thielman NM, Chu HY, Ostermann J, Itemba DK, Mgonja A, Mtweve S, et al. Cost-effectiveness of free HIV voluntary counseling and testing through a community-based AIDS service organization in Northern Tanzania. Am J Public Health. 2006; 96:114-9.10.2105/AJPH.2004.056796147044816317205Search in Google Scholar

27. Walensky RP, Weinstein MC, Smith HE, Freedberg KA, Paltiel AD. Optimal allocation of testing dollars: the example of HIV counseling, testing, and referral. Med Decis Making. 2005; 25:321-9.10.1177/0272989X0527695515951459Open DOISearch in Google Scholar